The Biological Excipient market is experiencing steady growth due to the rising demand for safe and biocompatible ingredients in pharmaceutical formulations. These inert substances derived from natural sources help enhance the stability, solubility, and bioavailability of active pharmaceutical ingredients. Despite challenges such as regulatory compliance and cost constraints, the market is expected to grow with the increasing focus on biopharmaceuticals and personalized medicine.
